跳至主要内容
临床试验/CTRI/2026/02/104742
CTRI/2026/02/104742尚未招募不适用

Ewing’sSarcoma with Intradural Involvement: An Ambispective Study

TATA MEMORIAL HOSPITAL1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年3月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
1

研究概览

简要总结

Ewing’s sarcoma is a bone and soft tissue tumour commonly seen in children and young adults. Ewing’s sarcoma is primarily treated with a combination of chemotherapy and local therapy, which includes surgery and/or radiation therapy. About 20% of these tumours arise in extra-osseous sites, out of which 1-2% of tumours are dural-based lesions.Unlike peripheral PNETs, meningeal Ewing’s sarcomas are locally invasive and have a higher propensity for haematogenous spread to lungs and bone marrow. Among Ewing’s sarcoma, there is a possibility that meningeal Ewing’s sarcoma may behave differently as compared to other extraosseous sites. The recurrence rate in these cases ranges from 40-60%, distant craniospinal axis failure was reported in 41.2%, and two-year survival rates in the range of 30-60%.Owing to the rarity of meningeal Ewing’s sarcomas, the management protocol of these tumours is non-uniform, with few reports of craniospinal radiotherapy at presentation. There is a lack of definite uniform data on its patterns of relapse, outcomes, and underlying demographic characteristics. This ambispective study aims to contribute to the existing literature on meningeal Ewing’s sarcoma by understanding the clinical demographics, patterns of failure, outcomes and prognostic factors; thereby improving clinical decisions and facilitating improved treatment approaches.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients diagnosed with histologically proven Ewing’s sarcoma of the dura, and vertebral/paravertebral/Chest wall/calvarial/skull base with intradural extension 2.Treated with radical intent at TMH/ACTREC from January 2013 to December 2030 (Partly treated in TMH/ACTREC or treatment advised from here) 3.Any age 4.With at least 6 months of follow-up.

排除标准

  • 1.Patients treated with palliative intent 2.Less than 6 months of follow-up 3.Referred outside or defaulted for treatment.

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Jifmi Jose Manjali

Tata Memorial Hospital

研究点 (1)

Loading locations...

相似试验